Business Segments · Total Assets

MedSurg and Neurotechnology — Total Assets

Stryker MedSurg and Neurotechnology — Total Assets increased by 1.4% to $27.28B in Q3 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ3 2025
Rolls up toTotal Assets

How to read this metric

An increase suggests expansion of the asset base, while a decrease may indicate divestitures or more efficient asset management.

Detailed definition

Represents the total economic resources controlled by the MedSurg and Neurotechnology segment, including inventory, prop...

Peer comparison

Standard balance sheet metric for segment reporting, comparable across manufacturing-heavy industries.

Metric ID: syk_segment_medsurg_and_neurotechnology_assets

Historical Data

7 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25
Value$15.22B$18.28B$20.51B$23.12B$26.91B$26.91B$27.28B
QoQ Change+20.1%+12.2%+12.7%+16.4%-0.0%+1.4%
YoY Change+20.1%+12.2%+12.7%
Range$15.22B$27.28B
CAGR+47.6%
Avg YoY Growth+15.0%
Median YoY Growth+12.7%

Frequently Asked Questions

What is Stryker's medsurg and neurotechnology — total assets?
Stryker (SYK) reported medsurg and neurotechnology — total assets of $27.28B in Q3 2025.
What does medsurg and neurotechnology — total assets mean?
The total value of resources and equipment owned by the MedSurg and Neurotechnology segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.